TickerFacts.

Charming Medical Ltd (MCTA): Cost of Revenue

Annual figures by period end, from SEC filings.

$35.2K
Year ended 2026-03-31
2024-03-31: $11.3K2025-03-31: $15.5K2026-03-31: $35.2K$35.2K
2024-03-31 Cost of Revenue (USD) 2026-03-31
Period endedCost of RevenueChange YoYSource filing
2026-03-31$35.2K+127.0%2026-07-30, From 2025-04-01
2025-03-31$15.5K+37.4%2026-07-30, From 2024-04-01
2024-03-31$11.3Kn/a2026-07-30, From 2023-04-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Charming Medical Ltd (MCTA)2026-03-31$35.2K+127.0%
Cryo Cell International Inc (CCEL)2025-11-30$7.38M-7.2%
Mangoceuticals, Inc. (MGRX)2025-12-31$54.4K-41.7%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$23.8K-15.1%
Viemed Healthcare, Inc. (VMD)2025-12-31$114.82M+26.1%
Sotera Health Co (SHC)2025-12-31$518.08M+4.0%
Progyny, Inc. (PGNY)2025-12-31$984.18M+7.7%

Compare MCTA, CCEL, MGRX, BRTX side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗